Literature DB >> 27157962

Use of herbs or vitamin/mineral/nutrient supplements by pediatric oncology patients.

Ayşe Bozkurt Turhan1, Özcan Bör2.   

Abstract

Use of complementary and alternative medicine (CAM) is widespread and increasing. We sought to study the frequency and factors affecting of its use in children with cancer. We designed a questionnaire that was administered to the parents of children between September 2013 and March 2014. A total of 74 patients were enrolled into the study. Fifty patients (67.5%) had used one or more than one type of herbs or vitamin/mineral/nutrient. The most commonly used CAM treatment was grape molasses (36.6%). The main source of information to families was the internet. No correlation found between the use of CAM and parents' education status, the level of income, socioeconomic status, chemotherapy treatment. Patients with cancer highly tended to use CAM treatment without informing healthcare professionals. The integration of complementary methods to the conventional treatments is interesting and seem to respond to the needs of patients allowing a more comprehensive approach to care.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alternative therapy; Cancer; Complementary therapy; Herbs; Pediatrics

Mesh:

Substances:

Year:  2016        PMID: 27157962     DOI: 10.1016/j.ctcp.2016.03.009

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  2 in total

1.  Black Seed Oil, Bentonite Clay, and Probiotics: A Comprehensive Holistic Cure for Clostridium difficile Infection in a 2-Year-Old Female Child.

Authors:  Emily Littman; Nicole Winningham; Tana B Carson; Ivette M Hidalgo
Journal:  Case Rep Infect Dis       Date:  2022-05-29

2.  Development of an evidence-based decision aid on complementary and alternative medicine (CAM) and pain for parents of children with cancer.

Authors:  Miek C Jong; Inge Boers; Herman van Wietmarschen; Martine Busch; Marianne C Naafs; Gertjan J L Kaspers; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2019-09-06       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.